Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Азербайджанский медицинский университет, Баку; 2ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава России, Москва; 3ГБУЗ Клиническая больница №5, Тбилиси, Грузия
Список исп. литературыСкрыть список 1. Carucci S. Growth on stimulant medication: effects in children with ADHD 26st European College of Neuropsychopharmacology. 2. Coghill D. Health-related quality of life outcomes in a long-term study of lisdexamfetamine dimesylate in children and adolescents with ADHD. 26st European College of Neuropsychopharmacology. 3. Cubillo F. Persistence of brain deficits in Adult ADHD. 26st European College of Neuropsychopharmacology. 4. Ecker С. New neuroimaging approaches in autism spectrum disorders. 26st European College of Neuropsychopharmacology. 5. Ehninger D. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol Med 2011; 17: 78–87. 6. Glennon J. Matching preclinical and clinical studies: the translational challenge. 26st European College of Neuropsychopharmacology. 7. Herbert M. Autism: from static genetic brain defect to dynamic gene-environment modulated pathopsysiology. 26st European College of Neuropsychopharmacology. 8. Herbert MR. Autism: from static genetic brain defect to dynamic gene-environment modulated pathopsysiology. Chapter 10 of Genetic Explanations: Sense and Nonsense. Eds S.Krimsky, J.Gruber. Harvard University Press, 2013; p. 122–46. 9. Persico A. Biomarkers and new target drugs in autism spectrum disorders. 26st European College of Neuropsychopharmacology. 10. Sobansky E. Psychopharmacological treatments for adults with ADHD: new findings. 26st European College of Neuropsychopharmacology.